Department of Cardiology, Shanghai Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China.
Atherosclerosis. 2011 Mar;215(1):203-8. doi: 10.1016/j.atherosclerosis.2010.11.019. Epub 2010 Nov 26.
The impact of gender on clinical course after ST-elevation myocardial infarction (STEMI) is not fully understood. We prospectively investigated whether there are gender-related differences in epicardial and myocardial tissue-level perfusion, both of which represent important prognostic determinants in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).
A total of 594 consecutive non-selected STEMI patients undergoing PPCI were prospectively enrolled. Primary end-point of the study was post-procedural epicardial and myocardial perfusion. Secondary end-points were the 30-day and 6-month composite occurrence of major adverse cardiac events (MACE).
Women with STEMI had higher risk factor profiles than men. Although PPCI achieved equal rates of successful epicardial reperfusion, women tended to have impaired microvascular reperfusion as reflected by lower rates of normal TIMI myocardial perfusion grade (P=0.007) and complete ST-segment resolution (P=0.079). After adjustment for the risk profiles, multivariable analysis showed that gender itself was not an independent predictor of impaired microvascular reperfusion. Both female gender and impaired myocardial reperfusion were independent predictors of 30-day MACE, whereas gender lost its prognostic significance for 6-month MACE. Multivariable analysis restricted to female patients identified incomplete ST-segment resolution as the strongest determinant of 30-day MACE.
The differences in microvascular reperfusion after PPCI between women and men are attributed to higher risk profiles in women. Both female gender and impaired myocardial reperfusion were independent predictors of 30-day outcomes after PPCI, emphasizing the importance of successful microvascular reperfusion in the women with STEMI.
性别对 ST 段抬高型心肌梗死(STEMI)后临床病程的影响尚未完全明确。我们前瞻性研究了在接受直接经皮冠状动脉介入治疗(PPCI)的 STEMI 患者中,心外膜和心肌组织水平灌注是否存在与性别相关的差异,两者均是 STEMI 患者重要的预后决定因素。
共前瞻性纳入 594 例连续非选择性 STEMI 行 PPCI 的患者。研究的主要终点是经皮冠状动脉介入治疗后的心外膜和心肌灌注。次要终点是 30 天和 6 个月时主要不良心脏事件(MACE)的复合发生率。
与男性相比,STEMI 女性的危险因素水平更高。尽管 PPCI 达到了相同的成功心外膜再灌注率,但女性倾向于存在微血管再灌注受损,表现为 TIMI 心肌灌注分级正常(P=0.007)和完全 ST 段回落(P=0.079)的比例较低。在调整风险状况后,多变量分析显示,性别本身并不是微血管再灌注受损的独立预测因子。女性性别和心肌再灌注受损均是 30 天 MACE 的独立预测因子,而性别对 6 个月 MACE 的预后意义丧失。将多变量分析限制在女性患者中,发现不完全 ST 段回落是 30 天 MACE 的最强预测因子。
女性与男性在 PPCI 后微血管再灌注的差异归因于女性的较高风险状况。女性性别和心肌再灌注受损均是 PPCI 后 30 天结局的独立预测因子,强调了成功实现 STEMI 女性患者微血管再灌注的重要性。